Bryan Linggi
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Retinoids in leukemia and cellular processes
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Protein Degradation and Inhibitors 3
- Genomics and Chromatin Dynamics 3
- Ubiquitin and proteasome pathways 2
- Oncology 8
- HER2/EGFR in Cancer Research 4
- Co-authors
- Guy H. Carpenter (1 shared paper)Scott W. Hiebert (8 shared papers)Bart Lutterbach (4 shared papers)Edward Seto (2 shared papers)Jennifer J. Westendorf (2 shared papers)Jennifer J. Westendorf (1 shared paper)Lye Meng Markillie (5 shared papers)H Wiley (5 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Journal of Crohn s and Colitis (3 papers)Science Signaling (1 paper)iScience (1 paper)Blood Cells Molecules and Diseases (1 paper)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Bryan Linggi
29 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 129
- Hematology 519
- Molecular Biology 1.4k
- Oncology 499
- Radiology, Nuclear Medicine and Imaging 218
- Cancer Research 126
Countries citing papers authored by Bryan Linggi
This map shows the geographic impact of Bryan Linggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Linggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Linggi more than expected).
Fields of papers citing papers by Bryan Linggi
This network shows the impact of papers produced by Bryan Linggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Linggi. The network helps show where Bryan Linggi may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Linggi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 363 | |
| 2 | 2006 | 289 | |
| 3 | 2009 | 276 | |
| 4 | 2000 | 219 | |
| 5 | 2002 | 203 | |
| 6 | 2011 | 108 | |
| 7 | 2000 | 91 | |
| 8 | 2014 | 73 | |
| 9 | 2006 | 50 | |
| 10 | 2005 | 49 | |
| 11 | 2013 | 46 | |
| 12 | 2005 | 43 | |
| 13 | 2013 | 43 | |
| 14 | 2013 | 29 | |
| 15 | 2021 | 23 | |
| 16 | 2014 | 23 | |
| 17 | 2001 | 23 | |
| 18 | 2003 | 20 | |
| 19 | 2003 | 17 | |
| 20 | 2020 | 14 |
About Bryan Linggi
Bryan Linggi is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Inflammatory Bowel Disease (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Protein Degradation and Inhibitors (3 papers), Genomics and Chromatin Dynamics (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hematology (519 citations), Molecular Biology (1.4k citations), Oncology (499 citations), Radiology, Nuclear Medicine and Imaging (218 citations) and Cancer Research (126 citations). Bryan Linggi has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Guy H. Carpenter, Scott W. Hiebert, Bart Lutterbach, Edward Seto, Jennifer J. Westendorf, Jennifer J. Westendorf, Lye Meng Markillie, H Wiley, Khanh D. Huynh and Mariko Moniwa. Their work appears in journals such as Journal of Biological Chemistry, Journal of Crohn s and Colitis, Science Signaling, iScience and Blood Cells Molecules and Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.